Explore how space-based crystallization enhances monoclonal antibodies for improved cancer therapy efficacy and patient access.
- Monoclonal antibodies (mAbs) have transformed cancer therapy by targeting tumor cells specifically and sparing healthy cells.
- Subcutaneous (SC) administration of mAbs is becoming more popular due to increased convenience and compliance for patients.
- Challenges with SC administration include limited dosing volume and increased viscosity of formulations, requiring novel approaches to development.
- Crystallization of mAbs in a microgravity environment offers advantages such as lower viscosity, improved stability, and enhanced therapeutic efficacy.
- Leveraging space-based crystallization techniques can lead to the development of more effective and patient-friendly mAb treatments for cancer patients worldwide.
Source link
Oncology, Radiology, Pharmacists